An interesting juxtaposition this week in MedCity. First, there was the researcher who longs to do nothing but research.
Then, by week’s end, we read of a program that hopes to do nothing but turn researchers into the next wave of biotech CEOs.
There were other notable developments as well. Read them over and have a great weekend.
presented by
Navina’s AI Copilot Eases the Value-Based Burden, Study Shows
A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices.
- Joblessness and uninsured go hand in hand, but some federal health-care proposals may stabilize the problems.
- Ganeden Biotech moved beyond humans with a probiotic for livestock feed.
- New products seems just around the corner in Minnesota and Indiana. CoAxia raised $21.5 million to complete trial of stroke device, and it looks like BioPoly is on track to commercialize its prosthetic technology.
- Ohio will get its first pluripotent stem cell facility — and advance a handful of commercialization projects — through a state grant and private match worth $10 million.
- Venture capital may be in a sad state, but there are still plenty of opportunities for health care.